The effect of alpha-cyclodextrin on post-prandial glucose excursions, a systematic meta analysis
Alpha-cyclodextrin (αCD) is a bacterial product that is widely used as a food ingredient. In the EU, αCD is regulated
Monosubstituted Maltosyl Cyclodextrins for the Potential Treatment of NPC
Niemann-Pick type C is a sever lysosomal storage disease, commonly refereed as ‘children’s Alzheimer’. There is no cure for it
The effect of alpha-cyclodextrin on post-prandial glucose excursions, a systematic meta analysis
Alpha-cyclodextrin (αCD) is a bacterial product that is widely used as a food ingredient. In the EU, αCD is regulated
Rapid Sublingual Delivery of Piroxicam from Electrospun Cyclodextrin Inclusion Complex Nanofibers
This study reports the development of rapidly dissolving cyclodextrin (CD)-based inclusion complex (IC) nanofibers by waterborne electrospinning for fast oral
Cyclodextrin polymer-confined urease for the fast and efficient removal of urea
Urease is a nickel-containing oligomer that can be used to catalyze the decomposition of urea. Free urease is unstable and
MIT scientists filed patent for HPBCD treatment in Alzheimer’s disease
Li-Huei Tsai, director of Picower Institute for Learning and Memory (Massachusetts Institute of Technology) and her coworkers recently filed a patent
Sugammadex, Subetadex and Sualphadex as chiral selectors
The present contribution describes for the first time the application of three single-isomeric cyclodextrin derivatives – Sugammadex, Subetadex and Sualphadex
Advances in the development of cyclodextrin-based nanogels/microgels for biomedical applications: Drug delivery and beyond
Nanogels/microgels are swollen cross-linked polymer networks with tunable physicochemical properties and are commonly employed for the effective delivery of hydrophilic
Cyclodextrin containing biocidal banknotes
GIESECKE+DEVRIENT CURRENCY TECHNOLOGY GMBH, a company founded 170 years ago, has filed a patent application on papers with biocidal properties
Emerging technologies to increase gastrointestinal transit times of drug delivery systems
Apart from already established technologies to increase gastrointestinal transit times, including devices rapidly increasing in size once they have reached
Inaugural Lecture of Prof. Szente at the Hungarian Academy of Sciences
Lajos Szente, Ph.D., D.Sc., one of the founders and former CEO (now Scientific Advisor) of CycloLab at the company and